Delisting riskPopularity #4,263
RNTX · NASDAQ · Biotechnology

Rein Therapeutics (RNTX)

Develops peptide candidates for pulmonary fibrosis and related lung diseases.

$0.7700
vs last close−0.02 (−3.11%)